Nanomedicine and Nanobiology
A section of Biomedicines (ISSN 2227-9059).
Section Information
This Section of Biomedicines aims to rapidly publish contributions on synthesis, bioavailability, and biodistribution of nanomedicines; delivery, pharmacodynamics, and pharmacokinetics of nanomedicines; imaging; diagnostics; improved therapeutics; innovative biomaterials; and interactions of nanomaterials with cells, tissues, and living organisms.
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Innovations in Nanomedicine for Disease Management (Deadline: 31 July 2025)
- Next-Generation Nanoparticles: Innovations in Biomedical Applications and Theranostics (Deadline: 30 September 2025)
- Nanomaterials and Nanotechnology in Biomedical Research (Deadline: 31 October 2025)
- Nanoparticles and Biomaterials: Pioneering Innovations in Biomedical Device Engineering (Deadline: 30 November 2025)
- Nano-Based Drug Delivery and Drug Discovery (Deadline: 31 December 2025)
- Nanobiomaterials with Antimicrobial and Anticancer Applications: Second Edition (Deadline: 31 December 2025)
- Unleashing the Power of Innovative Nanoparticles for Enhanced Radiation Therapy (Deadline: 31 December 2025)
- Mitochondrial Function as a Target in Nanomedicine (Deadline: 31 December 2025)
- Nanoparticle-Based Drug Delivery in Cancer Therapy: Current Progress and Challenges (Deadline: 31 January 2026)
- Nanoparticles in Medicine: The Potential of “Empty” Nanoparticles and Future Challenges (Deadline: 31 January 2026)
- Nanotechnology in Pharmaceuticals (Deadline: 31 January 2026)
- Progress in Nanotechnology-Based Therapeutic Strategies (Deadline: 28 February 2026)
- Emerging Trends and Applications in Nanomedicine and Targeted Therapies (Deadline: 31 March 2026)
